This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

FTI Consulting Bolsters Health Solutions Team

Stocks in this article: FCN

WEST PALM BEACH, Fla., Oct. 11, 2012 /PRNewswire/ -- FTI Consulting, Inc. (NYSE: FCN), the global business advisory firm dedicated to helping organizations protect and enhance their enterprise value, today announced Phillip L. Polakoff, M.D., M.P.H., M.Env. Sc., and John T. Kelly, M.D., Ph.D., have joined the firm. Dr. Polakoff and Dr. Kelly join a distinguished team of more than 250 professionals, including physicians, nurses and administrators serving the critical healthcare industry as part of the firm's Health Solutions group.

Dr. Polakoff will serve as Senior Managing Director and Chief Medical Executive of the firm's Health Solutions group. Dr. Polakoff brings to FTI Consulting 35 years of experience in healthcare delivery, product development, network development, care management, organizational and business development, policy formulation and communications. Prior to joining FTI Consulting, Dr. Polakoff established Polakoff Boland LLC, a healthcare management consulting firm focused on clinical effectiveness and accountable care organization (ACO)/clinical integration development.

Dr. Kelly will serve as Managing Director of the firm's Health Solutions group and lead its Clinical Transformation offering. Dr. Kelly brings to FTI Consulting 30 years of experience as a physician, manager and consultant with senior management roles in clinical performance improvement, healthcare quality management and clinical information management. In his new role, Dr. Kelly will focus on providing performance improvement and ACO/clinical integration development for health systems, payers and other clients seeking to enhance the quality, efficiency and excellence of clinical care delivery. Prior to joining FTI Consulting, Dr. Kelly was a partner at Polakoff Boland LLC and Chief Medical Officer at Huron Consulting.

"FTI Consulting has built a position of market leadership, impressive credentials, established reputation, and a strong history of internal collaboration and cooperation," said Ken Barker, Senior Managing Director and National Leader of the firm's Health Solutions group. "FTI Consulting is committed to enhancing our offerings in the face of extraordinary competition for talent in the attractive healthcare industry and we are honored to be the employer of choice for leading talent. The addition of Dr. Polakoff and Dr. Kelly illustrates our commitment to serving our healthcare clients with best-in-class human capital."

Gerry Meklaus, Senior Managing Director of the Health Solutions group and head of the Clinical Solutions service line at FTI Consulting, said, "The inclusion of Dr. Polakoff and Dr. Kelly in the group will enhance the firm's ability to offer our clients deep insight and winning guidance on their response to health reform. I look forward to working with them in supporting and enhancing our firm's innovative clinical solutions to meet today's challenges, which necessarily involve a restructuring of how care is delivered."

Dr. Polakoff said, "At this critical time in the evolution of healthcare transformation, I am excited to be joining a firm with the global reach and reputation of FTI Consulting. Over the last year, I have had the good fortune to partner with FTI Consulting on numerous provider and payer engagements, and its team of health experts has demonstrated a thorough understanding of how to deliver practical, collaborative, cost-effective solutions to clients."

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs